HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vascular endothelial growth factor and type 2 receptor for this factor in vascular malformations.

Abstract
Immunohistochemical study revealed higher level of VEGF expression in vascular malformations compared to that in normal vessels of the adjacent tissue. VEGF expression was slightly higher in the endothelium of arteriovenous angiodysplasias than in venous angiodysplasias. Enzyme immunoassay of tissue extracts showed that the concentrations of VEGF and VEGFR2 differ in arteriovenous and venous malformations. The concentrations of VEGF and VEGFR2 differed more significantly in primary and recurrent forms of arteriovenous angiodysplasias (as compared to venous angiodysplasias).
AuthorsK A Pavlov, E S Gershtein, E A Dubova, A I Shchegolev
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 150 Issue 4 Pg. 481-4 (Feb 2011) ISSN: 1573-8221 [Electronic] United States
PMID22268049 (Publication Type: Journal Article)
Chemical References
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Adult
  • Aged
  • Angiodysplasia (pathology)
  • Endothelium, Vascular (metabolism, pathology)
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Vascular Endothelial Growth Factor A (genetics, metabolism)
  • Vascular Endothelial Growth Factor Receptor-2 (genetics, metabolism)
  • Vascular Malformations (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: